Sino Biopharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sino Biopharmaceutical Limited with three other
companies in this sector in Hong Kong:
The United Laboratories International Holdings Limited
sales of 8.89 billion Hong Kong Dollars [US$1.14 billion]
of which 45%
was Bulk Medicine),
CSPC Pharmaceutical Group Ltd
(21.03 billion Hong Kong Dollars [US$2.69 billion]
of which 79%
was Finished Drugs), and
China Traditional Chinese Medicine Holdings Co Ltd
(13.33 billion Hong Kong Dollars [US$1.70 billion]
of which 64%
was Concentrated TCM Granules).
During the year ended December of 2018, sales at
Sino Biopharmaceutical Limited were HK$24.73 billion (US$3.16 billion).
increase of 44.2%
versus 2017, when the company's sales were HK$17.15 billion.
This was the fifth consecutive year of sales increases at Sino Biopharmaceutical Limited
(and since 2013, sales have increased a total of 150%).
Sales of Modernized Chinese Medicines and Chemica saw an increase
44.8% in 2018, from
HK$16.63 billion to HK$24.07 billion.